SureTrader SPDR Advertisement
Home > Boards > US Listed > Biotechs >

Inovio Pharmaceuticals, Inc. (INO)

INO RSS Feed
Add INO Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator biovalidator, TomP1
Search This Board:
Last Post: 9/2/2015 5:40:23 PM - Followers: 398 - Board type: Free - Posts Today: 0

Logo: Inovio

www.inovio.com/

http://finance.yahoo.com/q/ks?s=INO

http://finance.aol.com/company/inovio-biomedical-corporation/ino/ase/institutional-ownership

F
ebruary 12, 2014 Inovio CEO Dr. Joseph Kim rings bell to open trading on NYSE- http://www.youtube.com/watch?v=95yO6hFpbUM


Float: 97.65 M

Shares Outstanding: 127.26 M


Inovio Biomedical Corporation engages in the design, development, and delivery of a new generation of vaccines, called DNA vaccines, focused on cancers and infectious diseases. The company?s SynCon technology enables the design of DNA-based vaccines capable of providing cross-protection against evolving, unmatched strains of pathogens, such as influenza. Inovio?s proprietary electroporation DNA delivery technology uses brief, controlled electrical pulses to increase cellular DNA vaccine uptake. The company also has access to formulation and manufacturing expertise, and technology through its controlling ownership in VGX International. Inovio?s clinical programs include trials for HPV/cervical cancer (therapeutic) and HIV vaccines; and an IND has been filed for an avian influenza vaccine. Its partners and collaborators include Roche,Merck, Tripep, University of Southampton, University of Pennsylvania, HIV Vaccines Trial Network, and National Microbiology Laboratory of the Public Health Agency of Canada. The company was formerly known as Genetronics Biomedical Corp. and changed its name to Inovio Biomedical Corporation in March 2005. The company was founded in 1983 and is based in San Diego, California.

Currently Inovio has 12 clinical studies ( HIV, Influenza, Malaria, Hepatitis B, Hepatitis C, Breast and Lung cancer, Prostate Cancer, Head and Neck cancer, Cervical Cancer, Cervical dysplasia caused by HPV) ongoing from preclinical to phase 2.
 
Sep 10, 2013
Roche and Inovio Pharmaceuticals partner on Inovio's prostate cancer and hepatitis B immunotherapy products. Roche will make an upfront payment of USD $10 million to Inovio. Roche will also provide preclinical R&D support and payments for near-term regulatory milestones as well as payments upon reaching certain development and commercial milestones potentially up to USD $412.5 million. Additional development milestone payments could also be made to Inovio if Roche pursues other indications with INO-5150 or INO-1800.  In addition, Inovio is entitled to receive up to double-digit tiered royalties on product sales.

VGX-3100-Phase 2 Clinical Trial initiated for the treatment Cervical dysplasia (cervical intraepithelial neoplasia or CIN) caused by HPV
Top line data release Mid 2014
May 13, 2014:  Inovio Pharmaceuticals Acquires Early Stage DNA Therapies to Treat Alzheimer's and Multiple Sclerosis
http://finance.yahoo.com/news/inovio-pharmaceuticals-acquires-early-stage-080000624.html?.tsrc=applewf

May 23, 2014: Inovio Pharmaceuticals Announces 1 For 4 Reverse Split
http://finance.yahoo.com/news/inovio-pharmaceuticals-announces-1-4-080000629.html
1-for-4 reverse stock split shall become effective at 5 P.M., Thursday, June 5, 2014, and trading of the Company's common stock on a post-reverse split basis shall commence on Friday, June 6, 2014.


Inovio’s goal is to revolutionize vaccines. With best-in-class immune responses from multiple vaccines in different disease areas, our synthetic vaccine technology is making big strides toward this important goal.



 
 



 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
INO
Current Price
Volume:
Bid Ask Day's Range
Wiki
PostSubject
#4698  Sticky Note Please stay on topic. The only topic to IH Admin [Dan] 08/02/13 01:15:33 PM
#13106   Heavy volume into close. News in the AM perhaps? Perkin78 09/02/15 05:40:22 PM
#13105   Nice find! TomP1 09/02/15 11:49:02 AM
#13104   Inovio is presenting at MERs conference in Korea biovalidator 09/02/15 10:02:18 AM
#13103   Yes, aria massive short covering! Ino next!! harry crumb 08/28/15 02:50:07 PM
#13102   Gotta have some patience, we are still below TomP1 08/28/15 02:41:03 PM
#13101   Not only "10" but 10 to the 10th nanopatent 08/28/15 02:35:38 PM
#13100   Ino 10 coming people! harry crumb 08/28/15 12:55:00 PM
#13099   Can Inovio Pharmaceuticals Finally Offer Investors a Bright Future? nanopatent 08/27/15 07:29:07 PM
#13098   A synthetic consensus anti–spike protein DNA vaccine induces nanopatent 08/20/15 09:42:15 AM
#13097   Vaccine against Middle East Mystery Disease Shows Promise nanopatent 08/20/15 09:31:42 AM
#13096   Good news - Inovio Pharmaceuticals DNA Vaccine Protects fireopal 08/19/15 04:09:19 PM
#13095   Insider SIMON BENITO bought 6,000 shares on biovalidator 08/17/15 12:41:18 PM
#13094   They just signed a $700 million deal with TOM611 08/16/15 08:56:32 PM
#13093   Watch this stock people, analysts have been upgrading harry crumb 08/16/15 11:10:49 AM
#13092   Who knows! nanopatent 08/14/15 09:45:12 PM
#13091   Hey nano patent. Been a while. Is noretreat 08/14/15 09:11:27 PM
#13090   Inovio Pharmaceuticals Receives Buy Rating from Brean Capital (INO) nanopatent 08/13/15 12:44:33 PM
#13089   definitely looking forward to when it happens and fireopal 08/12/15 06:42:18 PM
#13088   It takes money to make money! nanopatent 08/12/15 03:31:05 PM
#13087   I got in at $1, watched it go nanopatent 08/12/15 03:29:37 PM
#13086   Double another laugh, just stay positive would be kpisme 08/12/15 03:28:20 PM
#13085   I have been in for 2 years and TomP1 08/12/15 03:24:48 PM
#13084   Revisit this in 10 years. nanopatent 08/12/15 03:21:20 PM
#13083   $100 LOL, this can't stay over $8 without kpisme 08/12/15 03:19:31 PM
#13082   True. Look at their neighbour Greece today - nothing nanopatent 08/12/15 03:15:56 PM
#13081   I've read it before on so many other TomP1 08/12/15 03:03:53 PM
#13080   Too pragmatic! nanopatent 08/12/15 02:51:33 PM
#13079   Dreaming is nice but lets keep it realistic TomP1 08/12/15 02:16:55 PM
#13078   INO as a company with a $ trillion nanopatent 08/12/15 01:08:43 PM
#13077   Will AstraZeneca-MedImmune takeover INO? nanopatent 08/12/15 12:51:36 PM
#13076   $27.5m upfront on its own is $0.38 per ppnlf 08/12/15 11:17:59 AM
#13075   AstraZeneca Joins the World of Immunotherapy against Cancer nanopatent 08/12/15 11:00:47 AM
#13074   AstraZeneca allots $727 million to buy cancer treatment nanopatent 08/12/15 10:55:47 AM
#13073   INO is ready for uptrend jet1968 08/11/15 04:51:52 PM
#13072   Hang in there, it will pay off in TomP1 08/11/15 01:38:04 AM
#13071   I like your humour. TomP1 08/11/15 01:36:49 AM
#13070   Bought in before R/S.. Still in the red. ThatsThe1 08/10/15 08:54:24 PM
#13069   I'm in at 8.70 took my aqxp money. jet1968 08/10/15 07:24:38 PM
#13068   Here comes the next aqxp! Rick026 08/10/15 07:19:18 PM
#13067   What a great after hours! Rick026 08/10/15 07:17:47 PM
#13066   I bought it because Jim Cramer said so :-) Rick026 08/10/15 07:06:56 PM
#13065   he did and ceo on da show. mick 08/10/15 07:02:28 PM
#13064   Is she as cute as Jim? nanopatent 08/10/15 04:31:47 PM
#13063   Remember that 8$ really is only 2$ pre-RS. TomP1 08/10/15 03:32:44 PM
#13062   Such a pity Afuckerstein is on holiday! TomP1 08/10/15 03:29:43 PM
#13061   have been a believer in this one for fireopal 08/10/15 03:05:36 PM
#13060   Flipped this 3 times today already, nice profits, harry crumb 08/10/15 02:20:00 PM
#13059   Who cares about cramer, an his winers, its harry crumb 08/10/15 02:18:01 PM
#13058   For a company that has the greatest medical nanopatent 08/10/15 02:14:34 PM
#13057   Not really, if they shorted from 10 area harry crumb 08/10/15 02:09:53 PM
PostSubject